Evotec SE (EVO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in EUR.

Revenue Annual

0 300M 600M 900M 2020: 500.9M 2021: 618M 2022: 751.4M 2023: 781.4M 2024: 797M 2020 2021 2022 2023 2024

Gross Profit Annual

0 60M 120M 180M 2020: 125.7M 2021: 151.5M 2022: 174.1M 2023: 175.1M 2024: 114.9M 2020 2021 2022 2023 2024

Operating Income Annual

-150M -100M -50M 0 50M 100M 150M 2020: 48.6M 2021: 41M 2022: 20.9M 2023: -47.5M 2024: -142.5M 2020 2021 2022 2023 2024

Net Income Annual

-240M -160M -80M 0 80M 160M 240M 2020: 6.3M 2021: 215.5M 2022: -175.7M 2023: -83.9M 2024: -196.1M 2020 2021 2022 2023 2024

Cost of Revenue Annual

0 250M 500M 750M 2020: 375.2M 2021: 466.5M 2022: 577.4M 2023: 606.4M 2024: 682.1M 2020 2021 2022 2023 2024

Operating Cash Flow Annual

0 70M 140M 210M 2020: 44.7M 2021: 126.6M 2022: 205.8M 2023: 36.4M 2024: 18.2M 2020 2021 2022 2023 2024

Free Cash Flow Annual

-210M -140M -70M 0 70M 140M 210M 2020: -54.4M 2021: 7.7M 2022: 24.5M 2023: -176.9M 2024: -99.2M 2020 2021 2022 2023 2024

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 70M 140M 210M 2020: 153.8M 2021: 166.4M 2022: 176.7M 2023: 176.9M 2024: 177.3M 2020 2021 2022 2023 2024

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.